Agenda 9:00-9:20 Keynote speech - Destiny-Breast 09 Phase III clinical research and progress Dr. Sara M Tolaney, Dana Farber Cancer Center, Harvard Medical School 9:20-9:50 Expert commentary -To elaborate on the past and present of the DESTINY-Breast series of studies, predict the results of DB09 from DB03, who will be the overlord of advanced breast cancer research? From clinical data perspective: Dr. Sheng Luo, Duke University From clinical mechanism perspective: Dr. Youwen

Inauguring webinar of the CASE Direct series About this event Every year, we watch world-class clinical trial presentations at ASCO and ESMO and appreciate the marvelous works done by leading global Principal Investigators (PI). As a professional in clinical trial space, do you want to learn what’s behind the success of these clinical trials and these masters? Have you also dreamt of just being like them and present your own clinical research results on ASCO and ESMO? eChinaH